Necrosis and apoptosis after retinal ischemia: Involvement of NMDA- mediated excitotoxicity and p53

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 713-720

  Joo, Choun Ki ^a   Choi, Jun Sub ^a   Ko, Hyuk W ^b   Park, Kye Yoon ^b   Sohn, Seonghyang ^b   Chun, Myung H ^a   Oh, Young J ^c   Gwag, Byoung J ^b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA NICK TRANSLATION; INTRAOCULAR PRESSURE; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA BIPOLAR GANGLION CELL; RETINA ISCHEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION;

ANIMALS; APOPTOSIS; DIZOCILPINE MALEATE; DNA PRIMERS; EXCITATORY AMINO ACID ANTAGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; ISCHEMIA; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NECROSIS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; RETINAL DISEASES; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033052291     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
2. Olney JW. The toxic effects of glutamate and related compounds in the retina and the brain. Retina. 1982;2:341-359.
3. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci. 1987;7:369-379.
4. Gwag BJ, Koh JY, Demaro J, Ying HS, Jacquin MF, Choi DW. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience. 1997;77:393-401.
5. Kerr JFK, Harmon BV. The molecular basis of cell death. In: Tomei LD, Cape FO, eds. Apoptosis. New York: Cold Spring Harbor Laboratory 1991:5-29.
6. Sohn S, Kim EY, Gwag BJ. Glutamate neurotoxicity in mouse cortical neurons: atypical necrosis with DNA ladders and chromatin condensation. Neurosci Lett. 1998;240:1-4.
7. Dessi F, Charriaut-Marlangue C, Khrestchatisky M, Ben-Ari Y. Glutamate-induced neuronal death is not a programmed cell death in cerebellar cultures. J Neurochem. 1993;60:1953-1955.
8. Koh JY, Cotman CW. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res. 1992;587:233-240.
9. Goldberg MP, Weiss JH, Pham PC, Choi DW. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther. 1987;243:784-791.
10. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinozaline: a neuroprotectant for cerebral ischemia. Science. 1990;247:571-574.
11. Simon RP, Swan JH, Griffith T, Meldrum BS. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226:850-852.
12. Heron A, Pollard H, Dessi F, et al. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in rat brain. J Neurochem. 1993;61:1973-1976.
13. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 1993;24:2002-2009.
14. MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett. 1993;164:89-92.
15. Shigeno T, Yamasaki Y, Kato G, et al. Reduction of delayed neuronal death by inhibition of protein synthesis. Neurosci Lett. 1990; 120:117-119.
16. Charriaut-Marlangue C, Margaill I, Represa A, Popovici T, Plotkine M, Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Metab. 1996;16:186-194.
17. Du C, Hu R, Csernansky CA, Liu XZ, Hsu CY, Choi DW. Additive neuroprotective effects of dextrophan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 1996; 718:233-236.
18. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygenglucose deprivation in vitro. Neuroscience. 1995;68:615-619.
19. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 1993;362:849-852.
20. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-849.
21. Cirielli C, Riccioni T, Yang C, et al. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer. 1995;63:673-679.
22. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991;352:345-347.
23. Chopp M, Li Y, Zhang ZG, Frevtag SO. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Commun. 1992;182:1201-1207.
24. Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L, Gautam S. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 1994;25:849-856.
25. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA. 1994;91:7525-7529.
26. Crumrine RC, Thomas AL, Morgan PF. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flour Metab. 1994;14:887-891.
27. Enokido Y, Araki T, Tanaka K, Aizawa S, Hatanaka H. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur J Neurosci. 1996;8:1812-1821.
28. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci. 1996;16: 1337-1345.
29. Sakhi S, Gilmore W, Tran ND, Schreiber SS. p53-deficient mice are protected against adrenalectomy-induced apoptosis. Neuroreport. 1996;8:233-235.
30. El-Asrar AM, Morse PH, Maimone D, Torczynski E, Reder AT. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest Ophthalmol Vis Sci. 1992;33: 3436-3438.
31. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993;602:304-317.
32. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107: 409-411
33. Buchi ER. Cell Death in the rat retina after a pressure-induced ischemia-reperfusion insult: an electron microscopic study, I: Ganglion cell layer and inner nuclear layer. Exp Eye Res. 1992;55:605-613.
34. Joo CK, Park KY, Park MS, Gwag BJ, Choun MH. Occurrence of neuronal necrosis and apoptosis following the retinal ischemia: induction of p53 and bcl-2 mRNA. Soc Neurosci Abstr. 1996;26: 464.15.
35. Gwag BJ, Sessler FM, Waterhouse BD, Springer JE. Regulation of nerve growth factor mRNA in the hippocampal formation effects of N-methyl-D-aspartate receptor activation. Exp Neurol. 1993;121: 160-171.
36. Sucher NJ, Aizenman E, Lipton SA. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci. 1991;11:966-971.
37. Romano C, Price MT, Almli T, Olney JW. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina. Invest Ophthalmol Vis Sci. 1998;39:416-423.
38. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 1996;6:667-672.
39. Chen J, Zhu RL, Nakayama M, et al. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J Neurochem. 1996;67: 64-71.
40. McGahan L, Hakim AM, Robertson GS. Hippocampal myc and p53 expression following transient global ischemia. Mol Brain Res. 1998;56:133-145.
41. Nakayama M, Uchimura K, Zhu RL, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci. USA. 1998;95:10954-10959.
42. Gottron FJ, Ying HS, Choi DW. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol Cell Neurosci. 1997;9: 159-169.
43. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA. 1997;94: 2007-2012.
44. Schreiber SS, Sakhi S, Dugich-Djodjevic MM, Nichols NR. Tumor suppressor p53 induction and DNA damage in hippocampal granule cells after adrenalectomy. Exp Neurol. 1994;130: 368-376.
45. Rosenbaum DM, Rosenbaum PS, Aggarwal A, Kessler JA. Transgenic mice deficient in the p53 protein are resistant to transient retinal ischemia. Soc Neurosci Abstr. 1996;26:464.13.
46. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
47. Xiang H, Kinoshita Y, Knudson MC, Korsmeyer SJ, Schwartzkroin PA, Morrison RS. Bax involvement in p53-mediated neuronal cell Death. J Neurosci. In press.
48. Lawrence MS, McLaughlin JR, Sun GH, et al. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab. 1997;17:740-744.
49. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 1994;13: 1017-1030.